Form 8-K - Current report:
SEC Accession No. 0001558370-21-009865
Filing Date
2021-08-03
Accepted
2021-08-03 07:15:00
Documents
14
Period of Report
2021-08-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K incy-20210803x8k.htm   iXBRL 8-K 42656
2 EX-99.1 incy-20210803xex99d1.htm EX-99.1 610619
3 GRAPHIC incy-20210803xex99d1001.jpg GRAPHIC 5736
  Complete submission text file 0001558370-21-009865.txt   817246

Data Files

Seq Description Document Type Size
4 EX-101.SCH incy-20210803.xsd EX-101.SCH 3203
5 EX-101.LAB incy-20210803_lab.xml EX-101.LAB 15499
6 EX-101.PRE incy-20210803_pre.xml EX-101.PRE 10504
7 EXTRACTED XBRL INSTANCE DOCUMENT incy-20210803x8k_htm.xml XML 4622
Mailing Address 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803
Business Address 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803 3024986700
INCYTE CORP (Filer) CIK: 0000879169 (see all company filings)

EIN.: 943136539 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12400 | Film No.: 211137958
SIC: 8731 Services-Commercial Physical & Biological Research